Biopharmaceuticals Contract Manufacturing Market By Product, Source and Service - Global Industry Analysis And Forecast To 2027
Published On : October 2018 Pages : 180 Category: Biotechnology Report Code : HC101495
Biopharmaceuticals Contract Manufacturing Market By Product (Biosimilars, Biologics and Other Products), Source (Non-Mammalian and Mammalian) and Service (Packaging, Process Development, Analytical & QC Studies and Fill & Finish Operations) - Global Industry Analysis And Forecast To 2027
Industry Outlook
The field of biopharmaceutical parenteral manufacturing has extended as of late as more remedial biologics have been affirmed for the market. The biotechnology and pharmaceutical organizations keep on re-appropriating to the contract manufacturing organizations (CMOs) as an approach to fulfill their needs of fill-and-complete and diminish the risks. The filed is growing owing to factors like; rising establishment of CMOs across the globe, increasing development in the technology & new innovation taking place in this field, rising number of acquisitions & mergers, and other factors. Therefore, the Biopharmaceuticals Contract Manufacturing Market is anticipated to expand and has tremendous scope during the forecast period. The global Biopharmaceuticals Contract Manufacturing Market anticipated to flourish in the future by growing at a significantly higher CAGR.
Market Segmentation
On the basis of Type the market is segmented into Biosimilars, Biologics and Other Products. The Biologics section is dominating the market owing to increasing success in the field of biologics, large number of approvals related to biologics by the FDA, etc.
On the basis of Application the market is segmented into Non-Mammalian and Mammalian. The Mammalian section is leading the market due to rising rate of adoption for the biologics, more numbers of players involved in this market, etc.
On the basis of End User the market is segmented into Packaging, Process Development, Analytical & QC Studies and Fill & Finish Operations. The Process Development section is leading the market owing to rising expenditure related to the process downstream, and other factors.
Regional Insights
The North American region is leading the global Biopharmaceuticals Contract Manufacturing Market owing to increasing activities related to research & development.
Biopharmaceuticals Contract Manufacturing Market, By Region
-
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.
- AbbVie Inc.
- Boehringer Ingelheim GmbH
- WuXi Biologics
- Lonza
- Binex Co. Ltd.
- Inno Biologics Sdn Bhd
- Thermo Fisher Scientific Inc.
- Rentschler Biotechnologie GmbH
- Samsung BioLogics
- JRS PHARMA
- AGC Biologics
- TOYOBO CO. LTD
- ProBioGen
- FUJIFILM Diosynth Biotechnologies U.S.A. Inc.
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
o Biopharmaceuticals Contract Manufacturing Market, By Product, Estimates and Forecast, 2017-2027 ($Million)
o Biosimilars
o Biologics
o Other Products
o Biopharmaceuticals Contract Manufacturing Market, By Source, Estimates and Forecast, 2017-2027 ($Million)
o Non-Mammalian
o Mammalian
o Biopharmaceuticals Contract Manufacturing Market, By Service, Estimates and Forecast, 2017-2027 ($Million)
o Packaging
o Process Development
o Analytical & QC Studies
o Fill & Finish Operations
o Biopharmaceuticals Contract Manufacturing Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Biopharmaceuticals Contract Manufacturing Market, By Country
o U.S. Biopharmaceuticals Contract Manufacturing Market
o Canada Biopharmaceuticals Contract Manufacturing Market
o Mexico Biopharmaceuticals Contract Manufacturing Market
o Europe
§ Europe Biopharmaceuticals Contract Manufacturing Market, By Country
o Germany Biopharmaceuticals Contract Manufacturing Market
o UK Biopharmaceuticals Contract Manufacturing Market
o France Biopharmaceuticals Contract Manufacturing Market
o Russia Biopharmaceuticals Contract Manufacturing Market
o Italy Biopharmaceuticals Contract Manufacturing Market
o Rest of Europe Biopharmaceuticals Contract Manufacturing Market
o Asia-Pacific
§ Asia-Pacific Biopharmaceuticals Contract Manufacturing Market, By Country
o China Biopharmaceuticals Contract Manufacturing Market
o Japan Biopharmaceuticals Contract Manufacturing Market
o South Korea Biopharmaceuticals Contract Manufacturing Market
o India Biopharmaceuticals Contract Manufacturing Market
o Southeast Asia Biopharmaceuticals Contract Manufacturing Market
o Rest of Asia-Pacific Biopharmaceuticals Contract Manufacturing Market
o South America
§ South America Biopharmaceuticals Contract Manufacturing Market, By Country
o Brazil Biopharmaceuticals Contract Manufacturing Market
o Argentina Biopharmaceuticals Contract Manufacturing Market
o Columbia Biopharmaceuticals Contract Manufacturing Market
o Rest of South America Biopharmaceuticals Contract Manufacturing Market
o Middle East and Africa
§ Middle East and Africa Biopharmaceuticals Contract Manufacturing Market, By Country
o Saudi Arabia Biopharmaceuticals Contract Manufacturing Market
o UAE Biopharmaceuticals Contract Manufacturing Market
o Egypt Biopharmaceuticals Contract Manufacturing Market
o Nigeria Biopharmaceuticals Contract Manufacturing Market
o South Africa Biopharmaceuticals Contract Manufacturing Market
o Rest of MEA Biopharmaceuticals Contract Manufacturing Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. SWOT Analysis
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Biopharmaceuticals Contract Manufacturing Market, By Product
5.1. Introduction
5.2. Global Biopharmaceuticals Contract Manufacturing Revenue and Market Share by Product (2017-2027)
5.2.1. Global Biopharmaceuticals Contract Manufacturing Revenue and Revenue Share by Product (2017-2027)
5.3. Biosimilars
5.3.1. Global Biosimilars Revenue and Growth Rate (2017-2027)
5.4. Biologics
5.4.1. Global Biologics Revenue and Growth Rate (2017-2027)
5.5. Other Products
5.5.1. Global Other Products Revenue and Growth Rate (2017-2027)
6. Biopharmaceuticals Contract Manufacturing Market, By Source
6.1. Introduction
6.2. Global Biopharmaceuticals Contract Manufacturing Revenue and Market Share by Source (2017-2027)
6.2.1. Global Biopharmaceuticals Contract Manufacturing Revenue and Revenue Share by Source (2017-2027)
6.3. Non-Mammalian
6.3.1. Global Non-Mammalian Revenue and Growth Rate (2017-2027)
6.4. Mammalian
6.4.1. Global Mammalian Revenue and Growth Rate (2017-2027)
7. Biopharmaceuticals Contract Manufacturing Market, By Service
7.1. Introduction
7.2. Global Biopharmaceuticals Contract Manufacturing Revenue and Market Share by Service (2017-2027)
7.2.1. Global Biopharmaceuticals Contract Manufacturing Revenue and Revenue Share by Service (2017-2027)
7.3. Packaging
7.3.1. Global Packaging Revenue and Growth Rate (2017-2027)
7.4. Process Development
7.4.1. Global Process Development Revenue and Growth Rate (2017-2027)
7.5. Analytical & QC Studies
7.5.1. Global Analytical & QC Studies Revenue and Growth Rate (2017-2027)
7.6. Fill & Finish Operations
7.6.1. Global Fill & Finish Operations Revenue and Growth Rate (2017-2027)
8. Biopharmaceuticals Contract Manufacturing Market, By Region
8.1. Introduction
8.2. Global Biopharmaceuticals Contract Manufacturing Revenue and Market Share by Regions
8.2.1. Global Biopharmaceuticals Contract Manufacturing Revenue by Regions (2017-2027)
8.3. North America Biopharmaceuticals Contract Manufacturing by Countries
8.3.1. North America Biopharmaceuticals Contract Manufacturing Revenue and Growth Rate (2017-2027)
8.3.2. North America Biopharmaceuticals Contract Manufacturing Revenue (Million USD) by Countries (2017-2027)
8.3.3. United States
8.3.3.1. United States Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.4. Canada
8.3.4.1. Canada Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.5. Mexico
8.3.5.1. Mexico Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2027)
8.4. Europe Biopharmaceuticals Contract Manufacturing by Countries
8.4.1. Europe Biopharmaceuticals Contract Manufacturing Revenue and Growth Rate (2017-2027)
8.4.2. Europe Biopharmaceuticals Contract Manufacturing Revenue (Million USD) by Countries (2017-2027)
8.4.3. Germany
8.4.3.1. Germany Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.4. France
8.4.4.1. France Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.5. UK
8.4.5.1. UK Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.6. Russia
8.4.6.1. Russia Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.7. Italy
8.4.7.1. Italy Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.8. Rest of Europe
8.4.8.1. Rest of Europe Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2027)
8.5. Asia-Pacific Biopharmaceuticals Contract Manufacturing by Countries
8.5.1. Asia-Pacific Biopharmaceuticals Contract Manufacturing Revenue and Growth Rate (2017-2027)
8.5.2. Asia-Pacific Biopharmaceuticals Contract Manufacturing Revenue (Million USD) by Countries (2017-2027)
8.5.3. China
8.5.3.1. China Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.4. Japan
8.5.4.1. Japan Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.5. Korea
8.5.5.1. Korea Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.6. India
8.5.6.1. India Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.7. Southeast Asia
8.5.7.1. Southeast Asia Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.8. Rest of Asia-Pacific
8.5.8.1. Rest of Asia-Pacific Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2027)
8.6. South America Biopharmaceuticals Contract Manufacturing by Countries
8.6.1. South America Biopharmaceuticals Contract Manufacturing Revenue and Growth Rate (2017-2027)
8.6.2. South America Biopharmaceuticals Contract Manufacturing Revenue (Million USD) by Countries (2017-2027)
8.6.3. Brazil
8.6.3.1. Brazil Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.4. Argentina
8.6.4.1. Argentina Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.5. Columbia
8.6.5.1. Columbia Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.6. Rest of South America
8.6.6.1. Rest of South America Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2027)
8.7. Middle East and Africa Biopharmaceuticals Contract Manufacturing by Countries
8.7.1. Middle East and Africa Biopharmaceuticals Contract Manufacturing Revenue and Growth Rate (2017-2027)
8.7.2. Middle East and Africa Biopharmaceuticals Contract Manufacturing Revenue (Million USD) by Countries (2017-2027)
8.7.3. Saudi Arabia
8.7.3.1. Saudi Arabia Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.4. United Arab Emirates
8.7.4.1. United Arab Emirates Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.5. Egypt
8.7.5.1. Egypt Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.6. Nigeria
8.7.6.1. Nigeria Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.7. South Africa
8.7.7.1. South Africa Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.8. Turkey
8.7.8.1. Turkey Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.9. Rest of Middle East and Africa
8.7.9.1. Rest of Middle East and Africa Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2027)
9. Company Profiles
9.1. AbbVie Inc.
9.1.1. Business Overview
9.1.2. Service Portfolio
9.1.3. Strategic Developments
9.1.4. Revenue and Market Share
9.2. Boehringer Ingelheim GmbH
9.2.1. Business Overview
9.2.2. Service Portfolio
9.2.3. Strategic Developments
9.2.4. Revenue and Market Share
9.3. WuXi Biologics
9.3.1. Business Overview
9.3.2. Service Portfolio
9.3.3. Strategic Developments
9.3.4. Revenue and Market Share
9.4. Lonza
9.4.1. Business Overview
9.4.2. Service Portfolio
9.4.3. Strategic Developments
9.4.4. Revenue and Market Share
9.5. Binex Co. Ltd.
9.5.1. Business Overview
9.5.2. Service Portfolio
9.5.3. Strategic Developments
9.5.4. Revenue and Market Share
9.6. Inno Biologics Sdn Bhd
9.6.1. Business Overview
9.6.2. Service Portfolio
9.6.3. Strategic Developments
9.6.4. Revenue and Market Share
9.7. Thermo Fisher Scientific Inc.
9.7.1. Business Overview
9.7.2. Service Portfolio
9.7.3. Strategic Developments
9.7.4. Revenue and Market Share
9.8. Rentschler Biotechnologie GmbH
9.8.1. Business Overview
9.8.2. Service Portfolio
9.8.3. Strategic Developments
9.8.4. Revenue and Market Share
9.9. Samsung BioLogics
9.9.1. Business Overview
9.9.2. Service Portfolio
9.9.3. Strategic Developments
9.9.4. Revenue and Market Share
9.10. JRS PHARMA
9.10.1. Business Overview
9.10.2. Service Portfolio
9.10.3. Strategic Developments
9.10.4. Revenue and Market Share
9.11. AGC Biologics
9.11.1. Business Overview
9.11.2. Service Portfolio
9.11.3. Strategic Developments
9.11.4. Revenue and Market Share
9.12. TOYOBO CO. LTD
9.12.1. Business Overview
9.12.2. Service Portfolio
9.12.3. Strategic Developments
9.12.4. Revenue and Market Share
9.13. ProBioGen
9.13.1. Business Overview
9.13.2. Service Portfolio
9.13.3. Strategic Developments
9.13.4. Revenue and Market Share
9.14. FUJIFILM Diosynth Biotechnologies U.S.A. Inc.
9.14.1. Business Overview
9.14.2. Service Portfolio
9.14.3. Strategic Developments
9.14.4. Revenue and Market Share
10. Global Biopharmaceuticals Contract Manufacturing Market Competition, by Manufacturer
10.1. Global Biopharmaceuticals Contract Manufacturing Revenue and Market Share by Manufacturer (2017-2017)
10.2. Global Biopharmaceuticals Contract Manufacturing Price By Region (2017-2017)
10.3. Top 5 Biopharmaceuticals Contract Manufacturing Manufacturer Market Share
10.4. Market Competition Trend
11. Biopharmaceuticals Contract Manufacturing Market Forecast (2017-2027)
11.1. Global Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2027)
11.2. Biopharmaceuticals Contract Manufacturing Market Forecast by Regions (2017-2027)
11.2.1. North America Biopharmaceuticals Contract Manufacturing Market Forecast (2017-2027)
11.2.1.1. United States Biopharmaceuticals Contract Manufacturing Market Forecast (2017-2027)
11.2.1.2. Canada Biopharmaceuticals Contract Manufacturing Market Forecast (2017-2027)
11.2.1.3. Mexico Biopharmaceuticals Contract Manufacturing Market Forecast (2017-2027)
11.2.2. Europe Biopharmaceuticals Contract Manufacturing Market Forecast (2017-2027)
11.2.2.1. Germany Biopharmaceuticals Contract Manufacturing Market Forecast (2017-2027)
11.2.2.2. France Biopharmaceuticals Contract Manufacturing Market Forecast (2017-2027)
11.2.2.3. UK Biopharmaceuticals Contract Manufacturing Market Forecast (2017-2027)
11.2.2.4. Russia Biopharmaceuticals Contract Manufacturing Market Forecast (2017-2027)
11.2.2.5. Italy Biopharmaceuticals Contract Manufacturing Market Forecast (2017-2027)
11.2.2.6. Rest of Europe Biopharmaceuticals Contract Manufacturing Market Forecast (2017-2027)
11.2.3. Asia-Pacific Biopharmaceuticals Contract Manufacturing Market Forecast (2017-2027)
11.2.3.1. China Biopharmaceuticals Contract Manufacturing Market Forecast (2017-2027)
11.2.3.2. Japan Biopharmaceuticals Contract Manufacturing Market Forecast (2017-2027)
11.2.3.3. Korea Biopharmaceuticals Contract Manufacturing Market Forecast (2017-2027)
11.2.3.4. India Biopharmaceuticals Contract Manufacturing Market Forecast (2017-2027)
11.2.3.5. Southeast Asia Biopharmaceuticals Contract Manufacturing Market Forecast (2017-2027)
11.2.3.6. Rest of Asia-Pacific Biopharmaceuticals Contract Manufacturing Market Forecast (2017-2027)
11.2.4. South America Biopharmaceuticals Contract Manufacturing Market Forecast (2017-2027)
11.2.4.1. Brazil Biopharmaceuticals Contract Manufacturing Market Forecast (2017-2027)
11.2.4.2. Argentina Biopharmaceuticals Contract Manufacturing Market Forecast (2017-2027)
11.2.4.3. Columbia Biopharmaceuticals Contract Manufacturing Market Forecast (2017-2027)
11.2.4.4. Rest of South America Biopharmaceuticals Contract Manufacturing Market Forecast (2017-2027)
11.2.5. Middle East and Africa Biopharmaceuticals Contract Manufacturing Market Forecast (2017-2027)
11.2.5.1. Saudi Arabia Biopharmaceuticals Contract Manufacturing Market Forecast (2017-2027)
11.2.5.2. United Arab Emirates Biopharmaceuticals Contract Manufacturing Market Forecast (2017-2027)
11.2.5.3. Egypt Biopharmaceuticals Contract Manufacturing Market Forecast (2017-2027)
11.2.5.4. Nigeria Biopharmaceuticals Contract Manufacturing Market Forecast (2017-2027)
11.2.5.5. South Africa Biopharmaceuticals Contract Manufacturing Market Forecast (2017-2027)
11.2.5.6. Turkey Biopharmaceuticals Contract Manufacturing Market Forecast (2017-2027)
11.2.5.7. Rest of Middle East and Africa Biopharmaceuticals Contract Manufacturing Market Forecast (2017-2027)
11.3. Biopharmaceuticals Contract Manufacturing Market Forecast by Product (2017-2027)
11.3.1. Biopharmaceuticals Contract Manufacturing Forecast by Product (2017-2027)
11.3.2. Biopharmaceuticals Contract Manufacturing Market Share Forecast by Product (2017-2027)
11.4. Biopharmaceuticals Contract Manufacturing Market Forecast by Source (2017-2027)
11.4.1. Biopharmaceuticals Contract Manufacturing Forecast by Source (2017-2027)
11.4.2. Biopharmaceuticals Contract Manufacturing Market Share Forecast by Source (2017-2027)
11.5. Biopharmaceuticals Contract Manufacturing Market Forecast by Service (2017-2027)
11.5.1. Biopharmaceuticals Contract Manufacturing Forecast by Service (2017-2027)
11.5.2. Biopharmaceuticals Contract Manufacturing Market Share Forecast by Service (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Biopharmaceuticals Contract Manufacturing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Biopharmaceuticals Contract Manufacturing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Biopharmaceuticals Contract Manufacturing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Biopharmaceuticals Contract Manufacturing Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Biopharmaceuticals Contract Manufacturing Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Biopharmaceuticals Contract Manufacturing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Biopharmaceuticals Contract Manufacturing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Biopharmaceuticals Contract Manufacturing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Biopharmaceuticals Contract Manufacturing Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Biopharmaceuticals Contract Manufacturing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Biopharmaceuticals Contract Manufacturing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Biopharmaceuticals Contract Manufacturing Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Biopharmaceuticals Contract Manufacturing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Biopharmaceuticals Contract Manufacturing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Biopharmaceuticals Contract Manufacturing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Biopharmaceuticals Contract Manufacturing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Biopharmaceuticals Contract Manufacturing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Biopharmaceuticals Contract Manufacturing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Biopharmaceuticals Contract Manufacturing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Biopharmaceuticals Contract Manufacturing Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Biopharmaceuticals Contract Manufacturing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Biopharmaceuticals Contract Manufacturing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Biopharmaceuticals Contract Manufacturing Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Biopharmaceuticals Contract Manufacturing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Biopharmaceuticals Contract Manufacturing Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Biopharmaceuticals Contract Manufacturing Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Biopharmaceuticals Contract Manufacturing Revenue and Revenue Share by Product (2017-2018)
Figure Global Biosimilars Revenue and Growth Rate (2017-2018)
Figure Global Biologics Revenue and Growth Rate (2017-2018)
Figure Global Other Products Revenue and Growth Rate (2017-2018)
Table Global Biopharmaceuticals Contract Manufacturing Revenue and Revenue Share by Source (2017-2018)
Figure Global Non-Mammalian Revenue and Growth Rate (2017-2018)
Figure Global Mammalian Revenue and Growth Rate (2017-2018)
Table Global Biopharmaceuticals Contract Manufacturing Revenue and Revenue Share by Service (2017-2018)
Figure Global Packaging Revenue and Growth Rate (2017-2018)
Figure Global Process Development Revenue and Growth Rate (2017-2018)
Figure Global Analytical & QC Studies Revenue and Growth Rate (2017-2018)
Figure Global Fill & Finish Operations Revenue and Growth Rate (2017-2018)
Table Global Biopharmaceuticals Contract Manufacturing Revenue by Regions (2017-2018)
Figure North America Biopharmaceuticals Contract Manufacturing Growth Rate (2017-2018)
Figure North America Biopharmaceuticals Contract Manufacturing Revenue and Growth Rate (2017-2018)
Figure North America Biopharmaceuticals Contract Manufacturing by Countries (2017-2018)
Figure North America Biopharmaceuticals Contract Manufacturing Revenue (Million USD) by Countries (2017-2018)
Figure United States Biopharmaceuticals Contract Manufacturing Growth Rate (2017-2018)
Figure United States Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Biopharmaceuticals Contract Manufacturing Growth Rate (2017-2018)
Figure Canada Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Biopharmaceuticals Contract Manufacturing Growth Rate (2017-2018)
Figure Mexico Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Biopharmaceuticals Contract Manufacturing Growth Rate (2017-2018)
Figure Europe Biopharmaceuticals Contract Manufacturing Revenue and Growth Rate (2017-2018)
Figure Europe Biopharmaceuticals Contract Manufacturing by Countries (2017-2018)
Figure Europe Biopharmaceuticals Contract Manufacturing Revenue (Million USD) by Countries (2017-2018)
Figure Germany Biopharmaceuticals Contract Manufacturing Growth Rate (2017-2018)
Figure Germany Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Biopharmaceuticals Contract Manufacturing Growth Rate (2017-2018)
Figure France Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Biopharmaceuticals Contract Manufacturing Growth Rate (2017-2018)
Figure UK Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Biopharmaceuticals Contract Manufacturing Growth Rate (2017-2018)
Figure Russia Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Biopharmaceuticals Contract Manufacturing Growth Rate (2017-2018)
Figure Italy Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Biopharmaceuticals Contract Manufacturing Growth Rate (2017-2018)
Figure Rest of Europe Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Biopharmaceuticals Contract Manufacturing Growth Rate (2017-2018)
Figure Asia-Pacific Biopharmaceuticals Contract Manufacturing Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Biopharmaceuticals Contract Manufacturing by Countries (2017-2018)
Figure Asia-Pacific Biopharmaceuticals Contract Manufacturing Revenue (Million USD) by Countries (2017-2018)
Figure China Biopharmaceuticals Contract Manufacturing Growth Rate (2017-2018)
Figure China Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Biopharmaceuticals Contract Manufacturing Growth Rate (2017-2018)
Figure Japan Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Biopharmaceuticals Contract Manufacturing Growth Rate (2017-2018)
Figure Korea Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Biopharmaceuticals Contract Manufacturing Growth Rate (2017-2018)
Figure India Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Biopharmaceuticals Contract Manufacturing Growth Rate (2017-2018)
Figure Southeast Asia Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Biopharmaceuticals Contract Manufacturing Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Biopharmaceuticals Contract Manufacturing Growth Rate (2017-2018)
Figure South America Biopharmaceuticals Contract Manufacturing Revenue and Growth Rate (2017-2018)
Figure South America Biopharmaceuticals Contract Manufacturing by Countries (2017-2018)
Figure South America Biopharmaceuticals Contract Manufacturing Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Biopharmaceuticals Contract Manufacturing Growth Rate (2017-2018)
Figure Brazil Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Biopharmaceuticals Contract Manufacturing Growth Rate (2017-2018)
Figure Argentina Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Biopharmaceuticals Contract Manufacturing Growth Rate (2017-2018)
Figure Columbia Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Biopharmaceuticals Contract Manufacturing Growth Rate (2017-2018)
Figure Rest of South America Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Biopharmaceuticals Contract Manufacturing Growth Rate (2017-2018)
Figure Middle East and Africa Biopharmaceuticals Contract Manufacturing Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Biopharmaceuticals Contract Manufacturing by Countries (2017-2018)
Figure Middle East and Africa Biopharmaceuticals Contract Manufacturing Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Biopharmaceuticals Contract Manufacturing Growth Rate (2017-2018)
Figure Saudi Arabia Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Biopharmaceuticals Contract Manufacturing Growth Rate (2017-2018)
Figure United Arab Emirates Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Biopharmaceuticals Contract Manufacturing Growth Rate (2017-2018)
Figure Egypt Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Biopharmaceuticals Contract Manufacturing Growth Rate (2017-2018)
Figure Nigeria Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Biopharmaceuticals Contract Manufacturing Growth Rate (2017-2018)
Figure South Africa Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Biopharmaceuticals Contract Manufacturing Growth Rate (2017-2018)
Figure Turkey Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Biopharmaceuticals Contract Manufacturing Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2017-2018)
Table AbbVie Inc. Biopharmaceuticals Contract Manufacturing Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Boehringer Ingelheim GmbH Biopharmaceuticals Contract Manufacturing Price, Revenue, Gross Margin and Market Share (2017-2017)
Table WuXi Biologics Biopharmaceuticals Contract Manufacturing Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Lonza Biopharmaceuticals Contract Manufacturing Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Binex Co. Ltd. Biopharmaceuticals Contract Manufacturing Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Inno Biologics Sdn Bhd Biopharmaceuticals Contract Manufacturing Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Thermo Fisher Scientific Inc. Biopharmaceuticals Contract Manufacturing Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Rentschler Biotechnologie GmbH Biopharmaceuticals Contract Manufacturing Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Samsung BioLogics Biopharmaceuticals Contract Manufacturing Price, Revenue, Gross Margin and Market Share (2017-2017)
Table JRS PHARMA Biopharmaceuticals Contract Manufacturing Price, Revenue, Gross Margin and Market Share (2017-2017)
Table AGC Biologics Biopharmaceuticals Contract Manufacturing Price, Revenue, Gross Margin and Market Share (2017-2017)
Table TOYOBO CO. LTD Biopharmaceuticals Contract Manufacturing Price, Revenue, Gross Margin and Market Share (2017-2017)
Table ProBioGen Biopharmaceuticals Contract Manufacturing Price, Revenue, Gross Margin and Market Share (2017-2017)
Table FUJIFILM Diosynth Biotechnologies U.S.A. Inc. Biopharmaceuticals Contract Manufacturing Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Biopharmaceuticals Contract Manufacturing Market Share by Manufacturer
Figure Global Biopharmaceuticals Contract Manufacturing Revenue and Market Share by Manufacturer
Table Global Biopharmaceuticals Contract Manufacturing Price by Region (2017-2017)
Figure Top 5 Biopharmaceuticals Contract Manufacturing Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Biopharmaceuticals Contract Manufacturing Revenue (Millions USD) and Growth Rate (2018-2025)
Table Biopharmaceuticals Contract Manufacturing Market Forecast by Regions (2018-2025)
Figure North America Biopharmaceuticals Contract Manufacturing Market Forecast (2018-2025)
Figure United States Biopharmaceuticals Contract Manufacturing Market Forecast (2018-2025)
Figure Canada Biopharmaceuticals Contract Manufacturing Market Forecast (2018-2025)
Figure Mexico Biopharmaceuticals Contract Manufacturing Market Forecast (2018-2025)
Figure Europe Biopharmaceuticals Contract Manufacturing Market Forecast (2018-2025)
Figure Germany Biopharmaceuticals Contract Manufacturing Market Forecast (2018-2025)
Figure France Biopharmaceuticals Contract Manufacturing Market Forecast (2018-2025)
Figure UK Biopharmaceuticals Contract Manufacturing Market Forecast (2018-2025)
Figure Russia Biopharmaceuticals Contract Manufacturing Market Forecast (2018-2025)
Figure Italy Biopharmaceuticals Contract Manufacturing Market Forecast (2018-2025)
Figure Rest of Europe Biopharmaceuticals Contract Manufacturing Market Forecast (2018-2025)
Figure Asia-Pacific Biopharmaceuticals Contract Manufacturing Market Forecast (2018-2025)
Figure China Biopharmaceuticals Contract Manufacturing Market Forecast (2018-2025)
Figure Japan Biopharmaceuticals Contract Manufacturing Market Forecast (2018-2025)
Figure Korea Biopharmaceuticals Contract Manufacturing Market Forecast (2018-2025)
Figure India Biopharmaceuticals Contract Manufacturing Market Forecast (2018-2025)
Figure Southeast Asia Biopharmaceuticals Contract Manufacturing Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Biopharmaceuticals Contract Manufacturing Market Forecast (2018-2025)
Figure South America Biopharmaceuticals Contract Manufacturing Market Forecast (2018-2025)
Figure Brazil Biopharmaceuticals Contract Manufacturing Market Forecast (2018-2025)
Figure Argentina Biopharmaceuticals Contract Manufacturing Market Forecast (2018-2025)
Figure Columbia Biopharmaceuticals Contract Manufacturing Market Forecast (2018-2025)
Figure Rest of South America Biopharmaceuticals Contract Manufacturing Market Forecast (2018-2025)
Figure Middle East and Africa Biopharmaceuticals Contract Manufacturing Market Forecast (2018-2025)
Figure Saudi Arabia Biopharmaceuticals Contract Manufacturing Market Forecast (2018-2025)
Figure United Arab Emirates Biopharmaceuticals Contract Manufacturing Market Forecast (2018-2025)
Figure Egypt Biopharmaceuticals Contract Manufacturing Market Forecast (2018-2025)
Figure Nigeria Biopharmaceuticals Contract Manufacturing Market Forecast (2018-2025)
Figure South Africa Biopharmaceuticals Contract Manufacturing Market Forecast (2018-2025)
Figure Turkey Biopharmaceuticals Contract Manufacturing Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Biopharmaceuticals Contract Manufacturing Market Forecast (2018-2025)
Figure Global Biopharmaceuticals Contract Manufacturing Forecast by Product (2018-2025)
Figure Global Biopharmaceuticals Contract Manufacturing Market Share Forecast by Product (2018-2025)
Figure Global Biopharmaceuticals Contract Manufacturing Forecast by Product (2018-2025)
Figure Global Biopharmaceuticals Contract Manufacturing Forecast by Source (2018-2025)
Figure Global Biopharmaceuticals Contract Manufacturing Market Share Forecast by Source (2018-2025)
Figure Global Biopharmaceuticals Contract Manufacturing Forecast by Source (2018-2025)
Figure Global Biopharmaceuticals Contract Manufacturing Forecast by Service (2018-2025)
Figure Global Biopharmaceuticals Contract Manufacturing Market Share Forecast by Service (2018-2025)
Figure Global Biopharmaceuticals Contract Manufacturing Forecast by Service (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|